{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:24:18Z","timestamp":1787117058598,"version":"build-2736575974"},"reference-count":55,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013489","name":"Yakult Bio-Science Foundation","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/501100013489","id-type":"DOI","asserted-by":"publisher"}]},{"award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"https:\/\/ror.org\/051635438","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background\/Objectives: Pancreatic ductal adenocarcinoma (PDAC) is characterized by aggressive tumor biology and profound host vulnerability, including pancreatic exocrine insufficiency (PEI), maldigestion, malnutrition, cachexia, sarcopenia, frailty, systemic inflammation, and poor tolerance to multimodal therapy. Gut and intratumoral microbiota have been implicated in pancreatic carcinogenesis, tumor immunity, chemotherapy response, and postoperative outcomes. However, the clinical readiness of microbiome-informed supportive care in PDAC remains uncertain. Results: Current evidence supports plausible mechanistic links among PEI, maldigestion, dysbiosis, microbial metabolites, barrier dysfunction, systemic inflammation, cachexia, sarcopenia, and treatment intolerance. Nevertheless, PDAC microbiome research is limited by major heterogeneity in sampling sites, sequencing platforms, antibiotic exposure, biliary drainage, diet, treatment timing, tumor stage, and analytic pipelines. Evidence is also discordant, particularly regarding alpha diversity and reproducible microbial signatures. Low-biomass tissue contamination and incomplete consideration of fungal and multi-kingdom microbiota further limit interpretation. Conclusions: Microbiome disturbance should currently be viewed as an investigational modifier of nutritional vulnerability and treatment tolerance rather than as a validated clinical biomarker or therapeutic target in PDAC. A clinically responsible framework should distinguish what is actionable now\u2014nutrition screening, PEI management, inflammation and frailty assessment, body-composition evaluation, and treatment-exposure monitoring\u2014from what remains investigational, including microbiome profiling, microbial signatures, probiotics, prebiotics, fecal microbiota transplantation, and metabolite-guided intervention.<\/jats:p>","DOI":"10.3390\/cancers18162658","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:35:08Z","timestamp":1786984508000},"page":"2658","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Microbiome Disturbance, Nutritional Vulnerability, and Treatment Tolerance in Pancreatic Ductal Adenocarcinoma: Mechanistic Links and Clinical Readiness"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6076-6516","authenticated-orcid":false,"given":"Naotake","family":"Funamizu","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan"},{"name":"Department of Gastroenterological Surgery for Advanced Regional Healthcare, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutaka","family":"Ihara","sequence":"additional","affiliation":[{"name":"Clinical Research Promotion Unit, Clinical Therapeutic Trial Center, Ehime University Hospital, Toon 791-0295, Ehime, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Tamura","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0041-3298","authenticated-orcid":false,"given":"Yoshiaki","family":"Kamei","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzo","family":"Umeda","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Pancreatic and Breast Surgery, Ehime University Graduate School of Medicine, Toon 791-0295, Ehime, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,17]]},"reference":[{"key":"ref_1","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e000643","DOI":"10.1136\/bmjgast-2021-000643","article-title":"Consensus for the management of pancreatic exocrine insufficiency","volume":"8","author":"Phillips","year":"2021","journal-title":"BMJ Open Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1002\/ncp.11129","article-title":"Fat malabsorption in pancreatic cancer: Pathophysiology and management","volume":"39","author":"Murray","year":"2024","journal-title":"Nutr. Clin. Pract."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"L\u00e1inez Ramos-Bossini, A.J., G\u00e1mez Mart\u00ednez, A., Luengo G\u00f3mez, D., Valverde-L\u00f3pez, F., Melguizo, C., and Prados, J. (2024). Prevalence of sarcopenia determined by computed tomography in pancreatic cancer: A systematic review and meta-analysis. Cancers, 16.","DOI":"10.3390\/cancers16193356"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1245\/s10434-023-14426-y","article-title":"Prevalence and impact of frailty in pancreatic cancer: A systematic review and meta-analysis based on 35,191 patients","volume":"31","author":"Zhang","year":"2024","journal-title":"Ann. Surg. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"13644","DOI":"10.1038\/s41598-022-18077-z","article-title":"Geriatric nutritional risk index as a potential prognostic marker for patients with resectable pancreatic cancer: A single-center, retrospective cohort study","volume":"12","author":"Funamizu","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"17000","DOI":"10.1038\/s41598-025-02365-5","article-title":"Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study","volume":"15","author":"Funamizu","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1016\/j.clnu.2021.02.005","article-title":"ESPEN practical guideline: Clinical nutrition in cancer","volume":"40","author":"Muscaritoli","year":"2021","journal-title":"Clin. Nutr."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"100092","DOI":"10.1016\/j.esmoop.2021.100092","article-title":"Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines","volume":"6","author":"Arends","year":"2021","journal-title":"ESMO Open"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1200\/JCO.20.00611","article-title":"Management of cancer cachexia: ASCO guideline","volume":"38","author":"Roeland","year":"2020","journal-title":"J. Clin. Oncol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(23)01366-1","article-title":"NALIRIFOX versus nab-paclitaxel and gemcitabine in treatment-naive patients with metastatic pancreatic ductal adenocarcinoma (NAPOLI 3): A randomised, open-label, phase 3 trial","volume":"402","author":"Wainberg","year":"2023","journal-title":"Lancet"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"13189","DOI":"10.1038\/s41598-026-40757-3","article-title":"Efficacy and safety signals from early-phase studies of KRAS inhibition in pancreatic cancer","volume":"16","author":"Tiede","year":"2026","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"16801","DOI":"10.1038\/s41598-019-53041-4","article-title":"Fecal microbiome signatures of pancreatic cancer patients","volume":"9","author":"Half","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1136\/gutjnl-2021-324755","article-title":"A faecal microbiota signature with high specificity for pancreatic cancer","volume":"71","author":"Kartal","year":"2022","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/j.gastro.2022.03.054","article-title":"Metagenomic identification of microbial signatures predicting pancreatic cancer from a multinational study","volume":"163","author":"Nagata","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1097\/JS9.0000000000001724","article-title":"Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: A systematic review and meta-analysis","volume":"110","author":"Hong","year":"2024","journal-title":"Int. J. Surg."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1097\/SLA.0000000000006299","article-title":"Comprehensive assessment of the intrinsic pancreatic microbiome","volume":"282","author":"Eckhoff","year":"2025","journal-title":"Ann. Surg."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1126\/science.aah5043","article-title":"Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine","volume":"357","author":"Geller","year":"2017","journal-title":"Science"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2019.07.008","article-title":"Tumor microbiome diversity and composition influence pancreatic cancer outcomes","volume":"178","author":"Riquelme","year":"2019","journal-title":"Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.gastro.2018.04.001","article-title":"Gut microbiota promotes tumor growth in mice by modulating immune response","volume":"155","author":"Sethi","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"112314","DOI":"10.1016\/j.isci.2025.112314","article-title":"Microbiota as a state-of-the-art approach in precision medicine for pancreatic cancer management: A comprehensive systematic review","volume":"28","author":"Hesami","year":"2025","journal-title":"iScience"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Sobocki, B.K., Ka\u017amierczak-Siedlecka, K., Folwarski, M., Hawry\u0142kowicz, V., Makarewicz, W., and Stachowska, E. (2021). Pancreatic cancer and gut microbiome-related aspects: A comprehensive review and dietary recommendations. Nutrients, 13.","DOI":"10.3390\/nu13124425"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Panebianco, C., Vilani, A., Potenza, A., Favaro, E., Finocchiaro, C., Perri, F., and Pazienza, V. (2023). Targeting gut microbiota in cancer cachexia: Towards new treatment options. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24031849"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Gualtieri, P., Cianci, R., Frank, G., Pizzocaro, E., De Santis, G.L., Giannattasio, S., Merra, G., Butturini, G., De Lorenzo, A., and Di Renzo, L. (2023). Pancreatic ductal adenocarcinoma and nutrition: Exploring the role of diet and gut health. Nutrients, 15.","DOI":"10.3390\/nu15204465"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Halle-Smith, J.M., Hall, L.A., Powell-Brett, S.F., Merali, N., Frampton, A.E., Beggs, A.D., Moss, P., and Roberts, K.J. (2023). Pancreatic exocrine insufficiency and the gut microbiome in pancreatic cancer: A target for future diagnostic tests and therapies?. Cancers, 15.","DOI":"10.3390\/cancers15215140"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Bastos, A.R., Pereira-Marques, J., Ferreira, R.M., and Figueiredo, C. (2023). Harnessing the microbiome to reduce pancreatic cancer burden. Cancers, 15.","DOI":"10.3390\/cancers15092629"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Papa, V., Schepis, T., Coppola, G., Chiappetta, M.F., Del Vecchio, L.E., Rozera, T., Quero, G., Gasbarrini, A., Alfieri, S., and Papa, A. (2023). The role of microbiota in pancreatic cancer. Cancers, 15.","DOI":"10.3390\/cancers15123143"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41575-019-0242-7","article-title":"Microbiota in pancreatic health and disease: The next frontier in microbiome research","volume":"17","author":"Thomas","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kiriukova, M., de la Iglesia Garcia, D., Panic, N., Bozhychko, M., Avci, B., Maisonneuve, P., De-Madaria, E., Capurso, G., and Sandru, V. (2020). Pancreatic cancer malnutrition and pancreatic exocrine insufficiency in the course of chemotherapy in unresectable pancreatic cancer. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00495"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/2050640620938987","article-title":"Pancreatic exocrine insufficiency and pancreatic enzyme replacement therapy in patients with advanced pancreatic cancer: A systematic review and meta-analysis","volume":"8","author":"Avci","year":"2020","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_33","first-page":"1835","article-title":"Pancreatic cancer and supportive care\u2014Pancreatic exocrine insufficiency negatively impacts on quality of life","volume":"21","author":"Gooden","year":"2013","journal-title":"Support. Care Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijsu.2018.09.014","article-title":"Sarcopenia and sarcopenic obesity are significantly associated with poorer overall survival in patients with pancreatic cancer: Systematic review and meta-analysis","volume":"59","author":"Mintziras","year":"2018","journal-title":"Int. J. Surg."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/jcsm.12155","article-title":"Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer","volume":"8","author":"Bakens","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/hpb.12394","article-title":"Preoperative computed tomography assessment of skeletal muscle mass is valuable in predicting outcomes following hepatectomy for perihilar cholangiocarcinoma","volume":"17","author":"Coelen","year":"2015","journal-title":"HPB"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1245\/s10434-016-5715-0","article-title":"Modified frailty index predicts morbidity and mortality after pancreaticoduodenectomy","volume":"24","author":"Mogal","year":"2017","journal-title":"Ann. Surg. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Grinstead, C., and Yoon, S.L. (2025). Geriatric nutritional risk index (GNRI) and survival in pancreatic cancer: A retrospective study. Nutrients, 17.","DOI":"10.3390\/nu17030509"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.21037\/gs-2026-1-0138","article-title":"Frailty in hepatobiliary and pancreatic (HBP) surgery: A narrative review toward an HBP-specific, implementation-oriented framework","volume":"15","author":"Funamizu","year":"2026","journal-title":"Gland Surg."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Funamizu, N., Uraoka, M., Ito, C., Iwata, M., Sakamoto, A., Kamei, Y., and Umeda, Y. (2025). Nutritional status and chemotherapy completion in resectable pancreatic cancer: A narrative review. Curr. Oncol., 32.","DOI":"10.3390\/curroncol32090519"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/SLA.0000000000006210","article-title":"Microbiome dysbiosis with Enterococcus presence in the upper gastrointestinal tract is a risk factor for mortality in patients undergoing surgery for pancreatic cancer","volume":"281","author":"Renz","year":"2025","journal-title":"Ann. Surg."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"pkaf024","DOI":"10.1093\/jncics\/pkaf024","article-title":"Antibiotic treatment and survival in patients with resected, early-stage pancreatic ductal adenocarcinoma receiving chemotherapy","volume":"9","author":"Gong","year":"2025","journal-title":"JNCI Cancer Spectr."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Salter, S.J., Cox, M.J., Turek, E.M., Calus, S.T., Cookson, W.O., Moffatt, M.F., Turner, P., Parkhill, J., Loman, N.J., and Walker, A.W. (2014). Reagent and laboratory contamination can critically impact sequence-based microbiome analyses. BMC Biol., 12.","DOI":"10.1186\/s12915-014-0087-z"},{"key":"ref_45","first-page":"125","article-title":"Contamination in low microbial biomass microbiome studies: Issues and recommendations","volume":"7","author":"Eisenhofer","year":"2019","journal-title":"Microbiome"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cell.2016.05.041","article-title":"From dietary fiber to host physiology: Short-chain fatty acids as key bacterial metabolites","volume":"165","author":"Koh","year":"2016","journal-title":"Cell"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41420-020-00390-z","article-title":"ABCA8-mediated efflux of taurocholic acid contributes to gemcitabine insensitivity in human pancreatic cancer via the S1PR2-ERK pathway","volume":"7","author":"Yang","year":"2021","journal-title":"Cell Death Discov."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.2337\/db07-1403","article-title":"Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice","volume":"57","author":"Cani","year":"2008","journal-title":"Diabetes"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5483\/BMBRep.2023-0068","article-title":"The impact of cancer cachexia on gut microbiota composition and short-chain fatty acid metabolism in a murine model","volume":"56","author":"Jeong","year":"2023","journal-title":"BMB Rep."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jso.21392","article-title":"Lipopolysaccharide increases the invasive ability of pancreatic cancer cells through the TLR4\/MyD88 signaling pathway","volume":"100","author":"Ikebe","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"e0182025","DOI":"10.1128\/spectrum.01820-25","article-title":"Survival mechanism of pancreatic tumor bacteria and their ability to metabolize chemotherapy drugs","volume":"13","author":"Khan","year":"2025","journal-title":"Microbiol. Spectr."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Tajpara, P., Sobkowiak, M.J., Healy, K., Naud, S., G\u00fcndel, B., Halimi, A., Khan, Z.A., Gabarrini, G., Le Guyader, S., and Imreh, G. (2025). Patient-derived pancreatic tumor bacteria exhibit oncogenic properties and are recognized by MAIT cells in tumor spheroids. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1553034"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type-specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41586-019-1608-2","article-title":"The fungal mycobiome promotes pancreatic oncogenesis via activation of MBL","volume":"574","author":"Aykut","year":"2019","journal-title":"Nature"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.chom.2018.11.003","article-title":"Response to fungal dysbiosis by gut-resident CX3CR1+ mononuclear phagocytes aggravates allergic airway disease","volume":"24","author":"Li","year":"2018","journal-title":"Cell Host Microbe"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2658\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T04:30:25Z","timestamp":1787113825000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/16\/2658"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,17]]},"references-count":55,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["cancers18162658"],"URL":"https:\/\/doi.org\/10.3390\/cancers18162658","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,17]]}}}